November 2025

Through a new research and development funding agreement, the company will receive $700 million from Blackstone Life Sciences to support late-stage clinical development of sac-TMT.

In a compelling report released today, Novo Nordisk A/S (Bagsværd, Denmark) announced robust performance for the first nine months of 2025 along with noteworthy pipeline developments that reflect the company’s ambition to redefine the treatment of chronic and rare diseases.

In a historic leap for global health, an international team of scientists has developed the world’s first genetically engineered, product-ready snake antivenom — a potential game-changer for treating bites from some of Africa’s most lethal snakes, including cobras, mambas, and rinkhals.

The U.S. Food and Drug Administration (FDA) has announced new measures aimed at accelerating the development of biosimilar medicines and lowering the overall cost of biologic treatments in the United States.

Pharmaceutical major Cipla Limited has announced the signing of definitive agreements to acquire 100% equity stake in Inzpera Healthsciences Limited, a company engaged in developing and marketing differentiated paediatric and wellness products. The announcement was made through a corporate filing with the Bombay Stock Exchange

Bachelor / Diploma in Pharmacy Degree should be obtained from a recognized University. Should be registered with Pharmacy Council Candidate should have full knowledge of Gujarati, Hindi and English language and computer. 

Masters Degree in Chemical Engineering / Chemistry / Industrial Chemistry or M.Pharm in Pharmaceutics and Pharmaceutical Analysis or equivalent from a recognized university. The Indian Institute of Toxicology Research